Singapore Neokidney Moves Closer
Nextkidney BV, which makes the sorbent-based home hemodialysis Neokidney, has signed a deal to buy Dialyss Pte. Ltd. as it gears up for commercialization. Next up: a clinical trial in Singapore, then a European multicenter trial, with CE mark submission in 2023.
Read the full article » | Posted 02-15-2022
Related Articles
- Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026
- HollyTM Implantable Continuous Dialysis System Could be Ready for Human Trials Soon Posted 04-14-2026
- Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
- New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026